News
NWBO
0.380
-3.80%
-0.015
Weekly Report: what happened at NWBO last week (0715-0719)?
Weekly Report · 4d ago
Weekly Report: what happened at NWBO last week (0708-0712)?
Weekly Report · 07/15 12:04
Weekly Report: what happened at NWBO last week (0701-0705)?
Weekly Report · 07/08 12:06
Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth Opportunities
Over 77% Of All Shares Voted; Proposals Received Overwhelming Positive Votes at the 2023 Annual Meeting. Northwest Biotherapeutics is a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers. There was an exceptionally strong vote turnout of 961.7 million votes cast out of 1.2 billion shares.
PR Newswire · 07/03 15:56
Weekly Report: what happened at NWBO last week (0624-0628)?
Weekly Report · 07/01 12:07
Weekly Report: what happened at NWBO last week (0617-0621)?
Weekly Report · 06/24 12:17
Weekly Report: what happened at NWBO last week (0610-0614)?
Weekly Report · 06/17 12:05
Weekly Report: what happened at NWBO last week (0603-0607)?
Weekly Report · 06/10 12:08
Weekly Report: what happened at NWBO last week (0527-0531)?
Weekly Report · 06/03 12:12
Weekly Report: what happened at NWBO last week (0520-0524)?
Weekly Report · 05/27 12:18
Weekly Report: what happened at NWBO last week (0513-0517)?
Weekly Report · 05/20 12:08
Weekly Report: what happened at NWBO last week (0506-0510)?
Weekly Report · 05/13 12:26
Northwest Biotherapeutics, Inc. Form 10-Q: Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2024
Press release · 05/11 08:36
Weekly Report: what happened at NWBO last week (0429-0503)?
Weekly Report · 05/06 12:37
Weekly Report: what happened at NWBO last week (0422-0426)?
Weekly Report · 04/29 12:46
Weekly Report: what happened at NWBO last week (0415-0419)?
Weekly Report · 04/22 12:28
Weekly Report: what happened at NWBO last week (0408-0412)?
Weekly Report · 04/15 12:18
Weekly Report: what happened at NWBO last week (0401-0405)?
Weekly Report · 04/08 12:23
Weekly Report: what happened at NWBO last week (0325-0329)?
Weekly Report · 04/01 12:20
Weekly Report: what happened at NWBO last week (0318-0322)?
Weekly Report · 03/25 12:23
More
Webull provides a variety of real-time NWBO stock news. You can receive the latest news about Northwest Bio through multiple platforms. This information may help you make smarter investment decisions.
About NWBO
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct, is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and included treatment of a diverse range of more than a dozen types of cancers. The Company’s wholly owned subsidiaries include Flaskworks, LLC, Northwest Biotherapeutics Limited, Aracaris Capital, Ltd, Northwest Biotherapeutics B.V., and NW Bio GmbH.